ReviewTherapeutic advances in medical oncology2021

Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis.

Lei Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.